Post Marketing Surveillance
Showing 1 - 25 of >10,000
Assess the Safety of Fedratinib in Korean Myelofibrosis
Recruiting
- Primary Myelofibrosis
- +2 more
-
Seoul, Korea, Republic ofBristol-Myers Squibb YH
Oct 3, 2023
CTAG Dissection/Trauma Post Marketing Surveillance Japan
Completed
- Thoracic Aortic Aneurysm
- +2 more
- Conformable GORE® TAG® Thoracic Endoprosthesis
- (no location specified)
Jan 11, 2023
Luspatercept in Korean Myelodysplastic Syndrome or ß-thalassemia
Not yet recruiting
- Myelodysplastic Syndrome
- Beta Thalassemia
-
Seoul, Korea, Republic ofBristol-Myers Squibb YH
Oct 3, 2023
Assess Safety of Ozanimod in Moderate to Severe Active UC in
Not yet recruiting
- Ulcerative Colitis
-
Seoul, Korea, Republic ofBristol-Myers Squibb YH
Oct 3, 2023
Oral Azacitidine Maintenance Therapy in Korean Acute Myeloid
Not yet recruiting
- Acute Myeloid Leukemia
- Oral azacitidine
-
Seoul, Korea, Republic ofBristol-Myers Squibb YH
Oct 3, 2023
Besponsa Post Marketing Surveillance Study
Active, not recruiting
- Hematologic Maligmancy
- Inotuzumab ozogamicin
-
Seoul, Korea, Republic ofPfizer
Oct 10, 2022
Saphir Stem in Primary Hip Surgery
Recruiting
- Arthropathy of Hip
- hip arthroplasty with prosthesis
-
Toulouse, FranceHopital Ducuing
Dec 12, 2022
Post Marketing Surveillance(PMS) Study of Lorviqua in Korea
Not yet recruiting
- Metastatic ALK+ Non Small Cell Lung Cancer
-
Seoul, Korea, Republic ofPfizer
Jan 24, 2023
Assess Deucravacitinib Post-marketing Surveillance in Psoriasis
Not yet recruiting
- Psoriasis
-
Tosima-ku, Tokyo, JapanLocal Institution
Nov 22, 2022
Juvenile Idiopathic Arthritis
Not yet recruiting
- Psoriatic Arthritis, Juvenile
- Polyarticular Juvenile Idiopathic Arthritis
-
Seoul, Korea, Republic ofSeoul National University Hospital
Feb 22, 2023
Xeljanz (Registered) in Ulcerative Colitis Patients
Completed
- Ulcerative Colitis
- Non-intervention
-
Seoul, Korea, Republic ofPfizer
Nov 16, 2022
Korean Post-marketing Surveillance for Xeljanz XR
Recruiting
- Active Moderate to Severe Rheumatoid Arthritis
- Active Ankylosing Spondylitis
- Tofacitinib XR
-
Seoul, Korea, Republic ofPfizer
Oct 10, 2022
Safety Issues Trial in Surabaya (Diphtheria Antitoxin)
Completed
- Safety Issues
- Diphtheria Antitoxin
-
Surabaya, East Java, IndonesiaRSUD Dr. Soetomo
Sep 19, 2023
Ofev Capsules in Chronic Fibrosing Interstitial Lung Diseases
Active, not recruiting
- Lung Diseases, Interstitial
-
Tokyo, JapanNippon Boehringer Ingelheim Co., Ltd.
Jan 9, 2023
Data of Intravitreal Aflibercept Injection in Patients of Wet
Completed
- Wet Age-related Macular Degeneration
- Aflibercept (Eylea, BAY86-5321)
-
Multiple Locations, IndiaMany Locations
Feb 2, 2023
A Post Marketing Surveillance on Piqray in Korea
Recruiting
- Breast Cancer
- Piqray
-
Deogyang Gu Goyang Si, Gyeonggi Do, Korea, Republic of
- +4 more
Jan 16, 2023
Vyndamax® Capsules for Treatment of Transthyretin Amyloid
Recruiting
- ATTR-CM (Transthyretin Amyloid Cardiomyopathy)
- Vyndamax (tafamidis 61mg)
-
Seoul, Korea, Republic ofPfizer
Aug 16, 2022
Xolair® for Chronic Rhinosinusitis With Nasal Polyps
Recruiting
- Chronic Rhinosinusitis With Nasal Polyps
- Xolair
-
Bundang Gu, Gyeonggi Do, Korea, Republic ofNovartis Investigative Site
Jan 19, 2023
Niraparib in Treatment of Adult Approved Indications in South
Recruiting
- Ovarian Neoplasms
-
Busan, Korea, Republic ofInje University Haeundae Paik Hospital
Oct 19, 2022
Mavacamten in Korean Symptomatic Obstructive Hypertrophic
Not yet recruiting
- Obstructive Hypertrophic Cardiomyopathy
-
Seoul, Korea, Republic ofBristol-Myers Squibb YH
Nov 23, 2023